1. Home
  2. TRUG vs TLPH Comparison

TRUG vs TLPH Comparison

Compare TRUG & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRUG
  • TLPH
  • Stock Information
  • Founded
  • TRUG 1983
  • TLPH 2005
  • Country
  • TRUG United States
  • TLPH United States
  • Employees
  • TRUG N/A
  • TLPH N/A
  • Industry
  • TRUG
  • TLPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRUG
  • TLPH Health Care
  • Exchange
  • TRUG NYSE
  • TLPH Nasdaq
  • Market Cap
  • TRUG 7.4M
  • TLPH 12.7M
  • IPO Year
  • TRUG N/A
  • TLPH 2011
  • Fundamental
  • Price
  • TRUG $0.43
  • TLPH $0.64
  • Analyst Decision
  • TRUG Strong Buy
  • TLPH Strong Buy
  • Analyst Count
  • TRUG 1
  • TLPH 2
  • Target Price
  • TRUG $2.00
  • TLPH $4.50
  • AVG Volume (30 Days)
  • TRUG 11.9M
  • TLPH 95.8K
  • Earning Date
  • TRUG 02-12-2025
  • TLPH 11-13-2024
  • Dividend Yield
  • TRUG N/A
  • TLPH N/A
  • EPS Growth
  • TRUG N/A
  • TLPH N/A
  • EPS
  • TRUG N/A
  • TLPH N/A
  • Revenue
  • TRUG $21,917,131.00
  • TLPH $281,000.00
  • Revenue This Year
  • TRUG N/A
  • TLPH N/A
  • Revenue Next Year
  • TRUG N/A
  • TLPH N/A
  • P/E Ratio
  • TRUG N/A
  • TLPH N/A
  • Revenue Growth
  • TRUG 7.68
  • TLPH N/A
  • 52 Week Low
  • TRUG $0.35
  • TLPH $0.60
  • 52 Week High
  • TRUG $11.82
  • TLPH $1.61
  • Technical
  • Relative Strength Index (RSI)
  • TRUG 44.87
  • TLPH 39.75
  • Support Level
  • TRUG $0.35
  • TLPH $0.60
  • Resistance Level
  • TRUG $0.92
  • TLPH $0.76
  • Average True Range (ATR)
  • TRUG 0.11
  • TLPH 0.07
  • MACD
  • TRUG 0.00
  • TLPH -0.00
  • Stochastic Oscillator
  • TRUG 14.04
  • TLPH 17.65

About TRUG TRUGOLF HOLDINGS INC

TruGolf Holdings Inc is a indoor golf gaming solutions company. It has built video games ("Links"), innovative hardware solutions, and an all-new e-sports platform to connect golfers around the world with E6 CONNECT.

About TLPH Talphera Inc.

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Share on Social Networks: